Adma Biologics Inc is a biopharmaceutical firm focused on creating plasma-derived products to fight immune deficiencies and infectious diseases. With products like BIVIGAM and ASCENIV for immune disorders, and Nabi-HB for Hepatitis B exposure, they're at the forefront of immune therapy. They also have a pipeline targeting S. pneumonia infection and run plasma collection facilities. Based in Ramsey, New Jersey, Adma Biologics sells through distributors, pharmacies, and other providers, aiming to enhance patient health globally.
Stock buybacks have become one of the most misunderstood tools in corporate finance. On a recent episode of The Investing for Beginners Podcast, co-hosts Andrew Sather and Stephen Morris broke down when…
Omor Ibne Ehsan Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply higher. A small group of biotechs is building real commercial businesses around recently approved drugs,…
Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in your portfolio, but also because when you invest in them, you’re investing…
